Tracon Pharmaceuticals Inc
Formerly Lexington Pharmaceuticals, Inc.
Funding rounds
4 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Mar 2018 | $39 M | No. 4 | $10 to $50 million | equity, options | SEC | |
| Mar 2017 | $1 M | No. 3 | Under $2 million | equity | SEC | |
| Mar 2011 | $17 M | No. 2 | $10 to $50 million | equity | SEC | |
| Mar 2010 | $2 M | No. 1 | Under $2 million | debt, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Tracon Pharmaceuticals Inc chose not to state its revenue in its newest notice of a funding round (Apr 2018).
SEC Form D · Apr 2018
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Apr 2018
That is all the official record says: Tracon Pharmaceuticals Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
6 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Brookline Tracon Investment Fund II, LLC | Fund or asset manager | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| CSA Biotechnology Fund II, LLC | Fund or asset manager | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| JAFCO Super V3 Investment Limited Partnership | Fund or asset manager | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| Nea 14 GP, LTD | Company | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| NEA Partners 14, L.P. | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
| New Enterprise Associates 14, L.P. | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2015) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 15 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Charles P. Theuer | Executive officer | Apr 2018 |
| Patricia L. Bitar | Executive officer | Apr 2018 |
| H Casey Logan | Executive officer | May 2017 |
| Bonne Adams | Executive officer | Apr 2011 |
| Bryan Leigh | Executive officer | Apr 2011 |
| Sharon Real | Executive officer | Apr 2011 |
| Bonne P. Adams | Executive officer | Oct 2010 |
| Bryan E. Leigh | Executive officer | Oct 2010 |
| Sharon P. Real | Executive officer | Oct 2010 |
| Timothy M. Hofer | Executive officer | Oct 2010 |
| Charles P. Theuer | Director | Apr 2018 |
| J. Rainer Twiford | Director | Apr 2018 |
| Martin L. Mattingly | Director | Apr 2018 |
| Paul Rainer Walker | Director | Apr 2018 |
| Stephen Rainer Worland | Director | Apr 2018 |
| Ted Rainer Wang | Director | Apr 2018 |
| William L. Larue | Director | Apr 2018 |
| Martin Casey Mattingly | Director | May 2017 |
| William Casey Larue | Director | May 2017 |
| Hironori Rainer Hozoji | Director | Apr 2011 |
| Kenji Rainer Harada | Director | Apr 2011 |
| Myoung-Ok Rainer Kwon | Director | Apr 2011 |
| Bertrand C. Liang | Director | Oct 2010 |
| J. Jay Lobell | Director | Oct 2010 |
| James E. Cantrell | Director | Oct 2010 |
| John R. Bolton | Director | Oct 2010 |
| William C. Comer | Director | Oct 2010 |